Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell GSK plc (GSK) – GSK plc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

GSK trades at $58.21, near its pivot point of $58, with bullish technical signals from moving averages and strong support at $57. The stock shows robust fundamentals, including a P/E of 15.66 and net income margin of 17.5%, with recent earnings beats. Positive news includes FDA approvals for expanded vaccine use and promising oncology drug data.
Outlook is favorable due to earnings momentum and pipeline advancements, but risks include competitive pressures and regulatory scrutiny. Analyst consensus leans hold (55%), suggesting cautious optimism. The stock presents a balanced opportunity for growth-oriented investors with a focus on healthcare innovations.
Read full analysis

Key Stats

  • Market Cap
    $116.76B
  • Sector
    Health
  • 3M Drawdown
    -15.27%
  • Enterprise Value
    $136.32B
  • Dividend Yield
    3.05%
  • Typical Hold Time
    84 days
$58.19
52W Low: $34.64
11 Apr 2025
52W High: $61.18
18 Feb 2026

GSK plc (GSK) is currently valued at a market capitalization of $116.76B, with an enterprise value of $136.32B. Over the past 52 weeks, GSK plc has traded between a low of $34.64 and a high of $61.18, highlighting its annual price range. Over the past three months, GSK plc has recorded a drawdown of -15.27%, reflecting recent price volatility. GSK plc offers a dividend yield of 3.05%, with the most recent dividend of $0.49 paid on 20 Feb 26. On average, investors hold GSK plc for approximately 84 days, indicating typical investor behavior on the platform.

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.


Technical Indicators
|
|
|
Overall Summary
Bearish (15)Neutral (8)Bullish (4)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $116.76B
  • Sector
    Health
  • 3M Drawdown
    -15.27%
  • Enterprise Value
    $136.32B
  • Dividend Yield
    3.05%
  • Typical Hold Time
    84 days
$58.19
52W Low: $34.64
11 Apr 2025
52W High: $61.18
18 Feb 2026

GSK plc (GSK) is currently valued at a market capitalization of $116.76B, with an enterprise value of $136.32B. Over the past 52 weeks, GSK plc has traded between a low of $34.64 and a high of $61.18, highlighting its annual price range. Over the past three months, GSK plc has recorded a drawdown of -15.27%, reflecting recent price volatility. GSK plc offers a dividend yield of 3.05%, with the most recent dividend of $0.49 paid on 20 Feb 26. On average, investors hold GSK plc for approximately 84 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!